Fuller & Thaler Asset Management, Inc. Guardant Health, Inc. Transaction History
Fuller & Thaler Asset Management, Inc.
- $25.4 Billion
- Q1 2025
A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 1,965,721 shares of GH stock, worth $87.7 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
1,965,721
Previous 1,984,586
0.95%
Holding current value
$87.7 Million
Previous $60.6 Million
38.12%
% of portfolio
0.33%
Previous 0.24%
Shares
14 transactions
Others Institutions Holding GH
# of Institutions
401Shares Held
123MCall Options Held
1.43MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.1MShares$539 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$501 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$243 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$230 Million0.04% of portfolio
-
Baillie Gifford & CO4.81MShares$214 Million0.2% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.56B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...